Researcher.Life Logo

IRAQI JOURNAL OF HEMATOLOGY : Impact Factor & More

eISSN: 2543-2702pISSN: 2072-8069
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on IRAQI JOURNAL OF HEMATOLOGY

IRAQI JOURNAL OF HEMATOLOGY Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
Overview
Publisher WOLTERS KLUWER MEDKNOW PUBLICATIONS
Language English
Frequency Semi-annual
Publication Time17
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorThe National Center of Hematology/ Almustansiriya University
FrequencySemi-annual
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
Publication Time 17
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC-SA
OA statementVisit website
View less

Planning to publish in IRAQI JOURNAL OF HEMATOLOGY ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in IRAQI JOURNAL OF HEMATOLOGY

Natural killer T lymphocyte like cells function and cytokine production interferon γ and interleukin 10 in chronic myelogenous leukemia: Implications for immune surveillance
  • 5 Jan 2026
  • Iraqi Journal of Hematology
Health-related quality of life, bone mineral density, and trabecular bone score of children with B-thalassemia major after bone marrow transplantation
  • 5 Jan 2026
  • Iraqi Journal of Hematology
Treatment of infantile acute lymphoblastic leukemia, experience of a country with limited resources
  • 5 Jan 2026
  • Iraqi Journal of Hematology
Filgrastim-induced cutaneous vasculitis in a patient undergoing stem cell mobilization
  • 1 Jul 2025
  • Iraqi Journal of Hematology
Safety and efficacy of bosutinib in chronic myeloid leukemia patients after failure of previous tyrosine kinase inhibitors: A prospective study from Basrah, Iraq
  • 1 Jul 2025
  • Iraqi Journal of Hematology
Augmenting bone marrow donor registries to enhance diversity and participation
  • 1 Jul 2025
  • Iraqi Journal of Hematology
Natural killer T lymphocyte like cells function and cytokine production interferon γ and interleukin 10 in chronic myelogenous leukemia: Implications for immune surveillance
  • 5 Jan 2026
  • Iraqi Journal of Hematology
Health-related quality of life, bone mineral density, and trabecular bone score of children with B-thalassemia major after bone marrow transplantation
  • 5 Jan 2026
  • Iraqi Journal of Hematology
Treatment of infantile acute lymphoblastic leukemia, experience of a country with limited resources
  • 5 Jan 2026
  • Iraqi Journal of Hematology
Filgrastim-induced cutaneous vasculitis in a patient undergoing stem cell mobilization
  • 1 Jul 2025
  • Iraqi Journal of Hematology
Safety and efficacy of bosutinib in chronic myeloid leukemia patients after failure of previous tyrosine kinase inhibitors: A prospective study from Basrah, Iraq
  • 1 Jul 2025
  • Iraqi Journal of Hematology
Augmenting bone marrow donor registries to enhance diversity and participation
  • 1 Jul 2025
  • Iraqi Journal of Hematology

FAQs on IRAQI JOURNAL OF HEMATOLOGY